Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adriano Arguedas

Showing results (61-70 of 86) with videos related to

Pageof 9
Sort By:
Journal of Medical Economics|April 5, 2024
Cost-effectiveness and impact on infections and associated antimicrobial resistance of 20-valent pneumococcal conjugate vaccine in US children previously immunized with PCV13Mark H Rozenbaum, Liping Huang, Alejandro Cane, et al.
Journal of Medical Economics|March 28, 2025
Cost of invasive pneumococcal disease, all-cause pneumonia, and all-cause otitis media among commercial-insured US childrenAhuva Averin, Derek Weycker, Rotem Lapidot, et al.
The Pediatric Infectious Disease Journal|May 2, 2008
A randomized comparative study of levofloxacin versus amoxicillin/clavulanate for treatment of infants and young children with recurrent or persistent acute otitis mediaGary J Noel, Jeffrey L Blumer, Michael E Pichichero, et al.
Antimicrobial Agents and Chemotherapy|September 25, 2003
High-dose azithromycin versus high-dose amoxicillin-clavulanate for treatment of children with recurrent or persistent acute otitis mediaAntonio Arrieta, Adriano Arguedas, Pilar Fernandez, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 25, 2020
One-Year Quality of Life Post-Pneumonia Diagnosis in Japanese AdultsHenry A Glick, Taiga Miyazaki, Katsuji Hirano, et al.
The Journal of Infectious Diseases|March 20, 2025
Eighteen Year Longitudinal Study of Uncomplicated and Complex Acute Otitis Media during the Pneumococcal Conjugate Vaccine Era, 2006-2023Naoko Fuji, Frank N Salamone, Ravinder Kaur, et al.
The Pediatric Infectious Disease Journal|September 29, 2007
Comparative safety profile of levofloxacin in 2523 children with a focus on four specific musculoskeletal disordersGary J Noel, John S Bradley, Ralph E Kauffman, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 9, 2023
Burden of Lower Respiratory Tract Infections Preventable by Adult Immunization With 15- and 20-Valent Pneumococcal Conjugate Vaccines in the United StatesJoseph A Lewnard, Vennis Hong, Katia J Bruxvoort, et al.
Clinical Pediatrics|March 4, 2026
BinaxNOW <i>Streptococcus pneumoniae</i> Antigen Assay in Pleural Fluid for Detection of <i>S pneumoniae</i> in Children With EmpyemaMichael A Crawford, Lindsay R Grant, Antonio C Arrieta, et al.
Infectious Diseases and Therapy|March 16, 2024
Cost-Effectiveness of 20-Valent Pneumococcal Conjugate Vaccine Among US Children with Underlying Medical ConditionsMark H Rozenbaum, Erica Chilson, Raymond Farkouh, et al.
Pageof 9

Showing results (61-70 of 86) with videos related to

Sort By:
Pageof 9
Journal of Medical Economics|April 5, 2024
Cost-effectiveness and impact on infections and associated antimicrobial resistance of 20-valent pneumococcal conjugate vaccine in US children previously immunized with PCV13Mark H Rozenbaum, Liping Huang, Alejandro Cane, et al.
Journal of Medical Economics|March 28, 2025
Cost of invasive pneumococcal disease, all-cause pneumonia, and all-cause otitis media among commercial-insured US childrenAhuva Averin, Derek Weycker, Rotem Lapidot, et al.
The Pediatric Infectious Disease Journal|May 2, 2008
A randomized comparative study of levofloxacin versus amoxicillin/clavulanate for treatment of infants and young children with recurrent or persistent acute otitis mediaGary J Noel, Jeffrey L Blumer, Michael E Pichichero, et al.
Antimicrobial Agents and Chemotherapy|September 25, 2003
High-dose azithromycin versus high-dose amoxicillin-clavulanate for treatment of children with recurrent or persistent acute otitis mediaAntonio Arrieta, Adriano Arguedas, Pilar Fernandez, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 25, 2020
One-Year Quality of Life Post-Pneumonia Diagnosis in Japanese AdultsHenry A Glick, Taiga Miyazaki, Katsuji Hirano, et al.
The Journal of Infectious Diseases|March 20, 2025
Eighteen Year Longitudinal Study of Uncomplicated and Complex Acute Otitis Media during the Pneumococcal Conjugate Vaccine Era, 2006-2023Naoko Fuji, Frank N Salamone, Ravinder Kaur, et al.
The Pediatric Infectious Disease Journal|September 29, 2007
Comparative safety profile of levofloxacin in 2523 children with a focus on four specific musculoskeletal disordersGary J Noel, John S Bradley, Ralph E Kauffman, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 9, 2023
Burden of Lower Respiratory Tract Infections Preventable by Adult Immunization With 15- and 20-Valent Pneumococcal Conjugate Vaccines in the United StatesJoseph A Lewnard, Vennis Hong, Katia J Bruxvoort, et al.
Clinical Pediatrics|March 4, 2026
BinaxNOW <i>Streptococcus pneumoniae</i> Antigen Assay in Pleural Fluid for Detection of <i>S pneumoniae</i> in Children With EmpyemaMichael A Crawford, Lindsay R Grant, Antonio C Arrieta, et al.
Infectious Diseases and Therapy|March 16, 2024
Cost-Effectiveness of 20-Valent Pneumococcal Conjugate Vaccine Among US Children with Underlying Medical ConditionsMark H Rozenbaum, Erica Chilson, Raymond Farkouh, et al.
Pageof 9